About US
Contact us
-
AstraZeneca to sell drug rights to Covis Pharma in $371m dealAstraZeneca has agreed to divest its rights for Alvesco (ciclesonide), Omnaris and Zetonna (ciclesonide) medicines to Swiss speciality pharmaceutical firm Covis Pharma in a deal valued up to $371m. T2018/11/8
-
Sementis and Enesi Pharma partner to develop needle-free vaccinesAustralian biotechnology firm Sementis has entered into a research and development (R&D) partnership with UK-based Enesi Pharma for the development of potential vaccine candidates to treat peanut2018/11/7
-
Scotland seeks answers on Brexit costs to NHSScotland First Minister Nicola Sturgeon has urged the UK government to provide answers on how much Brexit will cost the country’s National Health Service (NHS). WithBrexitless than six months away, c2018/11/7
-
Sanofi signs $1bn drug development deal with Denali TherapeuticsSanofi has entered a deal valued at more than $1bn with US-based Denali Therapeutics to advance potential drug candidates for the treatment of neurological and systemic inflammatory diseases. DNL7472018/11/6
-
Yuhan licences lung cancer asset to Janssen in $1.25bn dealSouth Korean pharmaceutical company Yuhan has signed a licensing and cooperation agreement valued at up to $1.25bn with Janssen Biotech to out-license a lung cancer drug candidate called Lazertinib.2018/11/6
-
Pfizer weighing a $2B women's health sale, report says. Will it fare better than Allergan?Earlier this year, Pfizer struck out on a sale of its consumer health unit. But it may be ready to try its hand at another selloff. The New York drugmaker is weighing options for its women’s health l2018/11/5
-
Novo Nordisk expands job cuts to 1,300 as executives play down Lilly’s GLP-1 threatDiabetes giant Novo Nordisk has been slimming down this year, and now we know just how much. First it was 400 R&D jobs, then about 250 positions in the U.S., and now the company says it will have2018/11/5
-
Novo Nordisk leads pharma pack breaking into Reputation Institute’s corporate responsibility rankingBig pharma’s reputation may be on the upswing, at least when it comes to corporate responsibility. Last year only Johnson & Johnson cracked the top 100 in Reputation Institute’s annual measurement2018/10/31
-
Pfizer manufacturing ills mean ongoing shortages for hospitalsPfizer acknowledged Tuesday that it continues to struggle with manufacturing at some Hospira plants, an issue that bodes ill not just for investors but also for U.S. hospitals. The manufacturing probl2018/10/31
-
Abbott and AbbVie settle TriCor marketing caseAmerican healthcare company Abbott Laboratories and AbbVie have reached a $25m settlement with US authorities to resolve charges that they paid kickbacks to doctors to encourage them to prescribechole2018/10/30